Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.11
+0.01 (0.12%)
May 13, 2025, 4:00 PM - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 23 employees as of December 31, 2023. The number of employees decreased by 1 or -4.17% compared to the previous year.
Employees
23
Change (1Y)
-1
Growth (1Y)
-4.17%
Revenue / Employee
$30,490
Profits / Employee
$278,186
Market Cap
6.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ADXN News
- 2 days ago - Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - GlobeNewsWire
- 14 days ago - Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery - GlobeNewsWire
- 18 days ago - Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Addex Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 - GlobeNewsWire
- 4 months ago - Addex to Present at the 2025 Swiss Equities Baader Conference - GlobeNewsWire
- 6 months ago - Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire